Earnings Feed
Start Free
Qualigen Therapeutics, Inc.·4

Aug 4, 4:16 PM ET

Lotz Christopher L. 4

4 · Qualigen Therapeutics, Inc. · Filed Aug 4, 2022

Insider Transaction Report

Form 4
Period: 2022-07-11
Qualigen Therapeutics, Inc.QLGN
Lotz Christopher L.
VP of Finance, CFO.
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-07-11+100,000→ 100,000 total
    Exercise: $0.51Exp: 2032-07-11→ Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]Shares underlying the stock option vest over three years in equal annual installments from the date of grant.

Documents

2 files